Effects of opiates on blood rheology.

To evaluate the possible effect of opiates on blood rheology, the plasma fibrinogen, prothrombin time and leukocyte aggregation were measured in 75 heroin addicts categorized by the time of abstention from heroin and the administration of naltrexone (25 active heroin abusers, 25 abstaining for 1 week, 11 abstaining for at least 5 months and 14 abstaining for 1 month and taking naltrexone during this period). No difference was detected in prothrombin time, but the leukocyte aggregation and fibrinogen were significantly different among the four groups (p = 0.028 and p = 0.0001, respectively). In particular, fibrinogen was 318 +/- 10.9 mg/dL in heroin abusers, significantly higher than that of the remaining three groups; the percentage of aggregated leukocytes was 5.01 +/- 0.77 in heroin users, significantly higher than that of subjects abstaining for at least 5 months. The fibrinogen levels declined sharply with abstention and an additive effect was noted with the administration of naltrexone, but leukocyte aggregation changed more slowly, and the effect of naltrexone (if any) was weaker. These data indicate an adverse effect of opiates on blood rheology and suggest that further studies should be performed to evaluate whether naltrexone may be useful in the prevention of major ischemic syndromes in patients with hyperfibrinogenemia and, perhaps, in those with high levels of leukocyte aggregation.

[1]  G. Bernardi,et al.  Leukocyte aggregation in patients with chronic cerebrovascular disease , 1994, Acta neurologica Scandinavica.

[2]  A. Maseri,et al.  WEB 2086 inhibits neutrophil dependent increases in coronary resistance in blood perfused rabbit heart. , 1992, Cardiovascular Research.

[3]  S. Carta,et al.  Proposal of a new method to avoid misinterpretations in the evaluation of the leukergy test. , 1992, Scandinavian journal of clinical and laboratory investigation.

[4]  J. Marler,et al.  High-dose intravenous naloxone for the treatment of acute ischemic stroke. , 1990, Stroke.

[5]  R. Jensen,et al.  Severe non‐occlusive ischemic stroke in young heroin addicts , 1990, Acta Neurologica Scandinavica.

[6]  S. Berliner,et al.  Possible Role of Fibrinogen in the Aggregation of White Blood Cells , 1987, Thrombosis and Haemostasis.

[7]  G. Worthen Lipid mediators, neutrophils, and endothelial injury. , 1987, The American review of respiratory disease.

[8]  Z. Fishelson,et al.  The phenomenon of leukergy: induction and detection of leukocyte aggregation in whole human blood. , 1987, The Journal of laboratory and clinical medicine.

[9]  B. Lucchesi,et al.  Leukocytes and ischemia-induced myocardial injury. , 1986, Annual review of pharmacology and toxicology.

[10]  M. C. Stone,et al.  Plasma fibrinogen--a major coronary risk factor. , 1985, The Journal of the Royal College of General Practitioners.

[11]  W. Keane,et al.  Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. , 1985, Endocrinology.

[12]  N. Falke,et al.  Cell shape of polymorphonuclear leukocytes is influenced by opioids. , 1985, Immunobiology.

[13]  A. Ceriello,et al.  Fibrinogen Levels in Opiate Addicts , 1983, Thrombosis and Haemostasis.

[14]  M. Trémoulet,et al.  NALOXONE REVERSAL OF NEUROLOGICAL DEFICIT , 1982, The Lancet.

[15]  Y. Hosobuchi,et al.  NALOXONE REVERSAL OF ISCHAEMIC NEUROLOGICAL DEFICITS IN MAN , 1981, The Lancet.

[16]  A. Szczeklik,et al.  Morphine antagonises prostaglandin E1- mediated inhibition of human platelet aggregation , 1975, Nature.